October 28, 2024
The potential of glucagon-like peptide 1 (GLP-1) receptor agonists continues to grow more promising as new studies identify benefits beyond glucose control and weight loss. With […]
October 28, 2024
Trying to reduce your carbohydrate intake means going against nearly a million years of evolution. Humans are among a few species with multiple copies of certain […]
October 28, 2024
Punch excision (PE) followed by immediate cryotherapy could be a viable and simpler alternative to core excision (CE) for the treatment of recalcitrant keloids, according to […]
October 28, 2024
TOPLINE: Stroke rates in Californians with sickle cell disease (SCD) have increased in both children and adults in the post-STOP era. The cumulative incidence of first […]
October 28, 2024
TOPLINE: Long-term treatment with upadacitinib in adolescents with moderate to severe atopic dermatitis (AD) demonstrated sustained efficacy and an acceptable safety profile through 76 weeks across […]
October 28, 2024
SAN DIEGO — The significant kidney and cardiovascular benefits people with chronic kidney disease (CKD) show over 2 years of treatment with empagliflozin begin to subside […]
October 27, 2024
PHILADELPHIA — The mortality rate of early-onset colorectal cancer (EO-CRC) has increased considerably across the United States over the past two decades, with the effects most […]
October 27, 2024
SAN DIEGO — Dapagliflozin provides significant benefits in the treatment of chronic kidney disease (CKD) even when initiated in patients with the most severe stages of […]
October 26, 2024
SAN DIEGO — A strategy to improve the management of hospitalized patients with acute kidney injury (AKI) through rapid personalized recommendations made by a dedicated kidney […]